share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Apr 6 07:04
Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a series of open market sales transactions of Moderna's common stock on April 3, 2024. Afeyan disposed of a total of 15,000 shares at prices ranging from $97.47 to $104.15, resulting in a total market value of $1,525,268.12. Following these transactions, Afeyan directly holds 2,086,931 shares of Moderna. Additionally, Afeyan has indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a series of open market sales transactions of Moderna's common stock on April 3, 2024. Afeyan disposed of a total of 15,000 shares at prices ranging from $97.47 to $104.15, resulting in a total market value of $1,525,268.12. Following these transactions, Afeyan directly holds 2,086,931 shares of Moderna. Additionally, Afeyan has indirect beneficial ownership of 9,666,038 shares through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.